ERBB2 and breast carcinoma: It is also reported that the ablation of CHD4 causes a downregulation of PI3K protein levels, as well as decreased phosphorylation of AKT and ERK (important pro-survival and proliferation kinases), and induces p27KIP1 upregulation, simultaneously inhibiting ERBB2+ breast cancer cell proliferation [76].